# Pharmacogenetic Testing Among Home Health Patients

> **NCT02378220** · NA · COMPLETED · sponsor: **Genelex Corporation** · enrollment: 110 (actual)

## Conditions studied

- Adverse Drug Events
- Adverse Drug Reactions
- Drug Interaction Potentiation
- Drug Metabolism, Poor, CYP2D6-RELATED
- Drug Metabolism, Poor, CYP2C19-RELATED
- Cytochrome P450 Enzyme Deficiency
- Cytochrome P450 CYP2D6 Enzyme Deficiency
- Cytochrome P450 CYP2C9 Enzyme Deficiency
- Cytochrome P450 CYP2C19 Enzyme Deficiency
- Cytochrome P450 CYP3A Enzyme Deficiency
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
- Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant

## Interventions

- **GENETIC:** Pharmacogenetic testing

## Key facts

- **NCT ID:** NCT02378220
- **Lead sponsor:** Genelex Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02378220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02378220, "Pharmacogenetic Testing Among Home Health Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02378220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*